Chronic diarrhea caused by idiopathic bile acid malabsorption: an explanation at last

References

• Hofmann AF, Mysels KJ. Bile salts as biological surfactants. Coll. Surf.30, 145–173 (1988).
   Google Scholar
• Gass J, Vora H, Hofmann AF, Gray GM, Khosla C. Enhancement of dietary protein digestion by conjugated bile acids. Gastroenterology133, 16–23 (2007).
   PubMed Web of Science ®Google Scholar
• Hofmann AF, Hagey LR. Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell. Mol. Life Sci.65, 2461–2483 (2008).
   PubMed Web of Science ®Google Scholar
• Dawson PA, Lan T, Rao A. Bile acid transporters. J. Lipid Res. DOI: 10.1194/jlr.R900012-JLR200 (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Hofmann AF, Cravetto C, Molino G, Belforte G, Bona B. Simulation of the metabolism and enterohepatic circulation of endogenous deoxycholic acid in man using a physiological pharmacokinetic model for bile acid metabolism. Gastroenterology93, 693–709 (1987).
   PubMed Web of Science ®Google Scholar
• Keating N, Scharl MM, Marsh C, Ferguson G, Hofmann AF, Keely SJ. Physiological concentrations of bile acids downregulate agonist induced secretion in colonic epithelial cells. J. Cell. Mol. Med. DOI: 10.1111/j.1582-4934.2009.00838.x (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Chadwick VS, Gaginella TS, Carlson GL, Debongnie JC, Phillips SF, Hofmann AF. Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. J. Lab. Clin. Med.94(5), 661–674 (1979).
   PubMed Web of Science ®Google Scholar
• Keely S, Scharl M, Bertelsen LS, Hagey LR, Barrett KE, Hofmann AF. Bile acid induced secretion in polarized monolayers of T84 colonic epithelial cells: structure-activity relationships. Am. J. Physiol.292, G292–G297 (2007).
   Google Scholar
• Shefer S, Hauser S, Bekersky I, Mosbach EH. Feedback regulation of bile acid biosynthesis in the rat. J. Lipid Res.10, 646–655 (1969).
   PubMed Web of Science ®Google Scholar
• Vlahcevic ZR, Pandak WM, Stravitz RT. Regulation of bile acid biosynthesis. Gastroenterol. Clin. North Am.28, 1–25 (1999).
   PubMed Web of Science ®Google Scholar
• Parks DJ, Blanchard SG, Bledsoe RK et al. Bile acids: natural ligands for an orphan nuclear receptor. Science284, 1365–1368 (1999).
   PubMed Web of Science ®Google Scholar
• Makashima M, Okamoto AY, Repa JJ et al. Identification of a nuclear receptor for bile acids. Science284, 1362–1365 (1999).
   PubMed Web of Science ®Google Scholar
• Wang H, Chen J, Holister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell3, 543–553 (1999).
   PubMed Web of Science ®Google Scholar
• Lu TT, Makashima M, Repa JJ et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell6, 507–515 (2000).
   PubMed Web of Science ®Google Scholar
• Chiang JYL. Bile acids: regulation of synthesis. J. Lipid Res. DOI: 10.1194/jlr.R900010-JLR200 (2009) (Epub ahead of print).
   Google Scholar
• Pandak WM, Heuman DM, Hylemon PB, Chiang JYL, Vlahcevic ZR. Failure of intravenous infusion of taurocholate to down-regulate cholesterol 7 α-hydroxylase in rats with biliary fistulas. Gastroenterology108, 533–544 (1995).
   PubMed Web of Science ®Google Scholar
• Nagano M, Kuroki S, Mizuta A et al. Regulation of bile acid synthesis under reconstructed enterohepatic circulation in rats. Steroids69, 701–709 (2004).
   PubMed Web of Science ®Google Scholar
• Inagaki T, Choi M, Moschetta A et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab.2, 217–225 (2005).
   PubMed Web of Science ®Google Scholar
• Goetz R, Beenken A, Ibrahimi OA et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol. Cell Biol.27, 3417–3428 (2007).
   PubMed Web of Science ®Google Scholar
• Lin BC, Wang M, Blackmore C, Desnovers LR. Liver-specific activities of FGF19 require Klotho b. J. Biol. Chem.282, 27277–27284 (2007).
   PubMed Web of Science ®Google Scholar
• Wu X, Ge H, Gupte J et al. Co-receptor requirements for fibroblast growth factor-19 signaling. J. Biol. Chem.282, 29069–29072 (2007).
   PubMed Web of Science ®Google Scholar
• Yu C, Wang F, Kan M, Satoh J, Nabeshima Y, Nabeshima Y. Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J. Biol. Chem.275, 15482–15489 (2000).
   PubMed Web of Science ®Google Scholar
• Ito S, Fujimori T, Furuya A et al. Impaired negative feedback suppression of bile acid synthesis in mice lacking bklotho. J. Clin. Invest.115, 2202–2208 (2005).
   PubMed Web of Science ®Google Scholar
• Grundy SM, Ahrens EH Jr, Salen G. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J. Lab. Clin. Med.78, 94–121 (1971).
   PubMed Web of Science ®Google Scholar
• Miettinen TA. Relationship between faecal bile acids, absorption of fat and vitamin B12 and serum lipids in patients with ileal resections. Eur. J. Clin. Invest.1, 452–460 (1971).
   PubMed Web of Science ®Google Scholar
• Hofmann AF, Poley JR. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology62, 918–934 (1972).
   PubMed Web of Science ®Google Scholar
• Aldini R, Roda A, Festi D et al. Bile acid malabsorption and bile acid diarrhea in intestinal resection. Dig. Dis. Sci.27, 495–502 (1982).
   PubMed Web of Science ®Google Scholar
• McJunkin B, Fromm H, Sarva RP, Amin P. Factors in the mechanism of diarrhea in bile acid malabsorption: fecal pH – a key determinant. Gastroenterology80, 1454–1464 (1981).
   PubMed Web of Science ®Google Scholar
• Hofmann AF, Poley JR. Cholestyramine treatment of diarrhea associated with ileal resection. N. Engl. J. Med.281, 397–402 (1969).
   PubMed Web of Science ®Google Scholar
• Thaysen EH, Pedersen L. Idiopathic bile acid catharsis. Gut17, 965–970 (1975).
   Web of Science ®Google Scholar
• Williams AJ, Merrick MV, Eastwood MA. Idiopathic bile acid malabsorption – a review of clinical presentation, diagnosis, and response to treatment. Gut32, 1004–1006 (1991).
   PubMed Web of Science ®Google Scholar
• Smith MJ, Cherian P, Raju GS, Dawson BF, Mahon S, Bardhan KD. Bile salt malabsorption in persistent diarrhoea. J. R. Coll. Physicians Lond.34, 448–451 (2000).
   PubMedGoogle Scholar
• Galatola G. The prevalence of bile acid malabsorption in irritable bowel syndrome and the effect of cholestyramine: an uncontrolled open multicentre study. Eur. J. Gastroenterol. Hepatol.4, 533–537 (1992).
   Web of Science ®Google Scholar
• Wildt S, Norby Rasmussen S, Lysgard Madsen J et al. Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test. Scand. J. Gastroenterol.38, 826–830 (2003).
   PubMed Web of Science ®Google Scholar
• Tilburg AJ, de Rooij FW, van den Berg JW, van Blankenstein M. Primary bile acid diarrhoea without an ileal carrier defect: quantification of active bile acid transport across the ileal brush border membrane. Gut32, 500–503 (1991).
   PubMed Web of Science ®Google Scholar
• Bajor A, Kilander A, Fae A et al. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. Eur. J. Gastroenterol. Hepatol.18, 397–403 (2006).
   PubMed Web of Science ®Google Scholar
• Walters JRF, Tasleem AM, Omer OS, Brydon WG, Dew T, Le Roux CW. A new mechanism for bile acid diarrhea: excessive bile acid biosynthesis caused by defective fibroblast growth factor 19 release from the ileum. Clin. Gastro. Hepatol. DOI:10.1016/j.cgh.2009.04.024 (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Song KH, Li T, Owsley E, Strom S, Chiang JY. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α-hydroxylase gene expression. Hepatology49(1), 297–305 (2009).
   PubMed Web of Science ®Google Scholar
• Gälman C, Arvidsson T, Angelin B, Rudling M. Monitoring hepatic cholesterol 7 α-hydroxylase activity by assay of the stable bile acid intermediate 7 α-hydroxy-4-cholesten-3-one in peripheral blood. J. Lipid Res.44, 859–866 (2003).
   PubMed Web of Science ®Google Scholar
• Eusufzai S, Axelson M, Angelin B, Einarsson K. Serum 7α-hydroxy-4-cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: correlation to SeHCAT test. Gut34, 698–701 (1993).
   PubMed Web of Science ®Google Scholar
• Sauter GH, Munzing W, von Ritter C, Paumgartner G. Bile acid malabsorption a cause of chronic diarrhea: diagnostic value of 7α-hydroxy-4-cholest-3-one in serum. Dig. Dis. Sci.44, 14–19 (1999).
   PubMed Web of Science ®Google Scholar
• Brydon WG, Nyhlin H, Eastwood MA, Merrick MV. Serum 7 α-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur. J. Gastroenterol. Hepatol.8, 117–123 (1996).
   PubMed Web of Science ®Google Scholar
• Puleston J, Morgan H, Andreyev J. New treatment for bile salt malabsorption. Gut54, 441–442 (2005).
   PubMedGoogle Scholar
• Hofmann AF. The syndrome of ileal disease and the broken enterohepatic circulation: cholerheic enteropathy. Gastroenterology52, 752–757 (1967).
   PubMed Web of Science ®Google Scholar